경구 약물전달 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제제별, 유형별, 치료 분야별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Oral Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Formulation, By Type, By Therapy Area, By End User, By Region and Competition, 2020-2030F
상품코드:1878873
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 경구 약물전달 시장은 2024년에 1,297억 7,000만 달러라고 평가되어 있으며, 2030년까지 CAGR 7.80%로 성장하여 2,036억 5,000만 달러에 달할 것으로 예측됩니다.
세계 경구 약물전달 시장은 경구 경로로 투여되는 치료제의 개발, 제조 및 상용화에 특화된 제약 산업 부문을 포괄합니다. 이 방법은 환자의 편의성, 투약의 용이성, 다른 전달 방식에 비해 복약 순응도 향상 가능성 등 고유한 장점으로 인해 매우 선호되고 있습니다. 이 시장을 이끄는 주요 요인으로는 심혈관질환, 당뇨병, 암과 같은 만성질환의 전 세계적인 유병률 증가가 있으며, 이는 장기적인 약물 복용 계획을 필요로 합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
1,297억 7,000만 달러
시장 규모 : 2030년
2,036억 5,000만 달러
CAGR : 2025-2030년
7.8%
가장 빠르게 성장하는 부문
정제
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 경구 약물전달 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제형별(정제, 캡슐, 점안제, 액제 또는 시럽제)
유형별(서방형 제제, 구강붕해정, 기타)
치료 분야별(종양학, 근골격계, 면역학, 소화기계, 호흡기계, 순환기계, 기타)
최종사용자별(병원, 외래 수술 센터, 진단 센터, 클리닉, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 경구 약물전달 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 경구 약물전달 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 경구 약물전달 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 경구 약물전달 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 경구 약물전달 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 경구 약물전달 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Novartis AG
Biocon Ltd.
NovoNordisk A/S
F.Hoffmann-La Roche Ltd.
Bayer AG
Emishphere Technologies Inc.
Enteris Biopharma Inc.
Merrion Pharmaceuticals Plc.
Amgen Inc.
Pfizer Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Oral Drug Delivery Market, valued at USD 129.77 Billion in 2024, is projected to experience a CAGR of 7.80% to reach USD 203.65 Billion by 2030. The Global Oral Drug Delivery Market encompasses the segment of the pharmaceutical industry dedicated to developing, manufacturing, and commercializing therapeutic agents administered via the oral route. This method is highly favored due to its inherent patient convenience, ease of administration, and potential for improved compliance compared to other delivery methods. Key drivers propelling this market include the increasing global prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer, which necessitate long-term medication regimens.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 129.77 Billion
Market Size 2030
USD 203.65 Billion
CAGR 2025-2030
7.8%
Fastest Growing Segment
Tablets
Largest Market
North America
Key Market Drivers
Technological advancements in drug delivery systems and expanded investment in pharmaceutical research and development exert considerable influence on the Global Oral Drug Delivery Market. Innovations in solubility enhancement, controlled release mechanisms, and targeted delivery are broadening the range of orally administered therapies, including complex molecules once limited to injectable routes. These developments improve drug stability, bioavailability, and therapeutic precision. For instance, according to Fierce Biotech, in April 2025, Roche acquired Carmot Therapeutics for $2.7 billion in late 2023, securing access to three GLP-1 receptor agonists with potential for treating obesity, including oral administration. Such strategic investments emphasize the industry's dedication to patient-friendly oral formulations.
Key Market Challenges
A significant challenge impeding market expansion for oral drug delivery is the stringent regulatory approval processes. These complex procedures inherently increase the time and financial investment required to bring new oral formulations to market. This extended development timeline and heightened cost create substantial barriers for pharmaceutical companies, particularly those developing innovative therapies, by prolonging the period before potential revenue generation.
Key Market Trends
The development of personalized oral therapies is a significant trend reshaping the Global Oral Drug Delivery Market by moving towards treatments tailored to individual patient profiles. This approach leverages advancements in diagnostics and genomics to customize drug selection, dosage, and formulation, enhancing therapeutic efficacy and minimizing adverse effects. According to the Personalized Medicine Coalition (PMC), in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities. These approvals underscore a growing industry commitment to individualized treatment pathways.
Key Market Players
Novartis AG
Biocon Ltd.
NovoNordisk A/S
F.Hoffmann-La Roche Ltd.
Bayer AG
Emishphere Technologies Inc.
Enteris Biopharma Inc.
Merrion Pharmaceuticals Plc.
Amgen Inc.
Pfizer Inc.
Report Scope:
In this report, the Global Oral Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Oral Drug Delivery Market, By Formulation:
Tablets
Capsules
Drops
Liquid or Syrup
Oral Drug Delivery Market, By Type:
Controlled Release
Orodispersible Tablets
Others
Oral Drug Delivery Market, By Therapy Area:
Oncology
Musculoskeletal
Immunology
Gastrointestinal
Respiratory
Cardiovascular
Others
Oral Drug Delivery Market, By End User:
Hospitals
Ambulatory Surgical Centres
Diagnostic Centres
Clinics
Others
Oral Drug Delivery Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Oral Drug Delivery Market.
Available Customizations:
Global Oral Drug Delivery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Oral Drug Delivery Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)
5.2.2. By Type (Controlled Release, Orodispersible Tablets, Others)
5.2.3. By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others)
5.2.4. By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Oral Drug Delivery Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Formulation
6.2.2. By Type
6.2.3. By Therapy Area
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Oral Drug Delivery Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Formulation
6.3.1.2.2. By Type
6.3.1.2.3. By Therapy Area
6.3.1.2.4. By End User
6.3.2. Canada Oral Drug Delivery Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Formulation
6.3.2.2.2. By Type
6.3.2.2.3. By Therapy Area
6.3.2.2.4. By End User
6.3.3. Mexico Oral Drug Delivery Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Formulation
6.3.3.2.2. By Type
6.3.3.2.3. By Therapy Area
6.3.3.2.4. By End User
7. Europe Oral Drug Delivery Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Formulation
7.2.2. By Type
7.2.3. By Therapy Area
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Oral Drug Delivery Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Formulation
7.3.1.2.2. By Type
7.3.1.2.3. By Therapy Area
7.3.1.2.4. By End User
7.3.2. France Oral Drug Delivery Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Formulation
7.3.2.2.2. By Type
7.3.2.2.3. By Therapy Area
7.3.2.2.4. By End User
7.3.3. United Kingdom Oral Drug Delivery Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Formulation
7.3.3.2.2. By Type
7.3.3.2.3. By Therapy Area
7.3.3.2.4. By End User
7.3.4. Italy Oral Drug Delivery Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Formulation
7.3.4.2.2. By Type
7.3.4.2.3. By Therapy Area
7.3.4.2.4. By End User
7.3.5. Spain Oral Drug Delivery Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Formulation
7.3.5.2.2. By Type
7.3.5.2.3. By Therapy Area
7.3.5.2.4. By End User
8. Asia Pacific Oral Drug Delivery Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Formulation
8.2.2. By Type
8.2.3. By Therapy Area
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Oral Drug Delivery Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Formulation
8.3.1.2.2. By Type
8.3.1.2.3. By Therapy Area
8.3.1.2.4. By End User
8.3.2. India Oral Drug Delivery Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Formulation
8.3.2.2.2. By Type
8.3.2.2.3. By Therapy Area
8.3.2.2.4. By End User
8.3.3. Japan Oral Drug Delivery Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Formulation
8.3.3.2.2. By Type
8.3.3.2.3. By Therapy Area
8.3.3.2.4. By End User
8.3.4. South Korea Oral Drug Delivery Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Formulation
8.3.4.2.2. By Type
8.3.4.2.3. By Therapy Area
8.3.4.2.4. By End User
8.3.5. Australia Oral Drug Delivery Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Formulation
8.3.5.2.2. By Type
8.3.5.2.3. By Therapy Area
8.3.5.2.4. By End User
9. Middle East & Africa Oral Drug Delivery Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Formulation
9.2.2. By Type
9.2.3. By Therapy Area
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Oral Drug Delivery Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Formulation
9.3.1.2.2. By Type
9.3.1.2.3. By Therapy Area
9.3.1.2.4. By End User
9.3.2. UAE Oral Drug Delivery Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Formulation
9.3.2.2.2. By Type
9.3.2.2.3. By Therapy Area
9.3.2.2.4. By End User
9.3.3. South Africa Oral Drug Delivery Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Formulation
9.3.3.2.2. By Type
9.3.3.2.3. By Therapy Area
9.3.3.2.4. By End User
10. South America Oral Drug Delivery Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Formulation
10.2.2. By Type
10.2.3. By Therapy Area
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Oral Drug Delivery Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Formulation
10.3.1.2.2. By Type
10.3.1.2.3. By Therapy Area
10.3.1.2.4. By End User
10.3.2. Colombia Oral Drug Delivery Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Formulation
10.3.2.2.2. By Type
10.3.2.2.3. By Therapy Area
10.3.2.2.4. By End User
10.3.3. Argentina Oral Drug Delivery Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Formulation
10.3.3.2.2. By Type
10.3.3.2.3. By Therapy Area
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Oral Drug Delivery Market: SWOT Analysis
